Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques

The RV144 vaccine trial revealed a correlation between reduced risk of HIV infection and the level of nonneutralizing-antibody (Ab) responses targeting specific epitopes in the second variable domain (V2) of the HIV gp120 envelope (Env) protein, suggesting this region as a target for vaccine develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Devasundaram, Santhi, Rosati, Margherita, Valentin, Antonio, Weiss, Svenja, Itri, Vincenza, Trinh, Hung V., Bear, Jenifer, Chowdhury, Bhabadeb, LaBranche, Celia C., Montefiori, David, Ferrari, Guido, Rao, Mangala, Kong, Xiang-Peng, Zolla-Pazner, Susan, Pavlakis, George N., Felber, Barbara K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944456/
https://www.ncbi.nlm.nih.gov/pubmed/33087466
http://dx.doi.org/10.1128/JVI.01193-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944456/
https://www.ncbi.nlm.nih.gov/pubmed/33087466
http://dx.doi.org/10.1128/JVI.01193-20

Ejemplares similares